Xytis Begins Phase II Clinical Study With Anatibant (XY2405) For Traumatic Brain Injury

... Xytis announced it has received approval to initiate a Phase II clinical trial with Anatibant for the treatment of traumatic brain injury (TBI) in the United Kingdom and South Africa and enrollment of the first patient is expected this month. "We are working with the London School of Hygiene and Tropical Medicine (LSHTM), which conducted the largest clinical study in TBI to date. [click link for full article] ...